NeoGenomics, Inc. (NEO)

NeoGenomics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	331.91	342.49	263.18	316.83	228.71	173.02
Short-Term Investments	52.92	72.72	174.81	198.56	67.55	0
Cash & Cash Equivalents	384.83	415.2	437.99	515.39	296.26	173.02
Cash Growth	-7.92%	-5.20%	-15.02%	73.97%	71.23%	1663.49%
Receivables	140.28	131.23	119.71	112.13	106.84	94.24
Inventory	20.32	24.16	24.28	23.4	29.53	14.41
Other Current Assets	28.47	26.23	23.31	30.59	16.1	9.08
Total Current Assets	573.9	596.81	605.29	681.51	448.73	290.74
Property, Plant & Equipment	174.44	183.78	198.61	211.66	131.66	90.68
Long-Term Investments	0	0	0	0	51.47	0
Goodwill and Intangibles	887.53	895.89	931.03	969.44	331.74	325.24
Other Long-Term Assets	4.47	4.74	5.11	7.17	24.73	2.85
Total Long-Term Assets	1,066	1,084	1,135	1,188	539.6	418.77
Total Assets	1,640	1,681	1,740	1,870	988.33	709.51
Accounts Payable	18.34	20.33	20.51	17.92	24.97	19.57
Deferred Revenue	1.14	2.13	7.56	0	0	0
Current Debt	4.49	5.61	6.65	8.02	7.81	13.81
Other Current Liabilities	52.74	68.23	55.21	61.29	40.41	30.52
Total Current Liabilities	76.71	96.3	89.93	87.23	73.18	63.9
Long-Term Debt	603.7	606.07	604.27	604.77	211.38	119.06
Other Long-Term Liabilities	36.52	37.32	47.81	69.5	9.47	19.13
Total Long-Term Liabilities	640.22	643.39	652.08	674.27	220.85	138.19
Total Liabilities	716.93	739.69	742.01	761.5	294.04	202.1
Total Debt	608.18	611.68	610.93	612.79	219.19	132.88
Debt Growth	-0.35%	0.12%	-0.30%	179.57%	64.96%	18.32%
Retained Earnings	-274.12	-247.06	-159.09	-14.84	-7.19	-11.36
Comprehensive Income	-1.33	-1.67	-3.9	-0.64	0.01	-1.62
Shareholders' Equity	923.41	941.54	998.02	1,108	694.29	507.41
Net Cash / Debt	-223.35	-196.48	-172.94	-97.4	77.07	40.14
Net Cash / Debt Growth	-	-	-	-	91.99%	-
Net Cash Per Share	-1.77	-1.57	-1.39	-0.81	0.69	0.39
Working Capital	497.19	500.51	515.36	594.28	375.55	226.83
Book Value Per Share	7.32	7.50	8.04	9.24	6.39	5.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).